Cargando…
Ezetimibe prevents the development of non-alcoholic fatty liver disease induced by high-fat diet in C57BL/6J mice
There is currently no established treatment for non-alcoholic fatty liver disease (NAFLD), including its most extreme form, non-alcoholic steatohepatitis (NASH). Ezetimibe, an inhibitor of Niemann-Pick C1 Like 1-dependent cholesterol absorption, improves diet-induced hyperlipidemia and attenuates li...
Autores principales: | WANG, XIANG, REN, QIAOHUA, WU, TAO, GUO, YONG, LIANG, YONG, LIU, SUBO |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4227427/ https://www.ncbi.nlm.nih.gov/pubmed/25310357 http://dx.doi.org/10.3892/mmr.2014.2623 |
Ejemplares similares
-
Characteristics of intestinal microbiota in C57BL/6 mice with non-alcoholic fatty liver induced by high-fat diet
por: Yan, Guangwen, et al.
Publicado: (2022) -
Sodium fluorocitrate having inhibitory effect on fatty acid uptake ameliorates high fat diet-induced non-alcoholic fatty liver disease in C57BL/6J mice
por: Hong, Seung A., et al.
Publicado: (2019) -
Sinapine-enriched rapeseed oils reduced fatty liver formation in high-fat diet-fed C57BL/6J mice
por: Li, Youdong, et al.
Publicado: (2020) -
Nonalcoholic Fatty Liver Disease Induced by High-Fat Diet in C57bl/6 Models
por: Recena Aydos, Leonardo, et al.
Publicado: (2019) -
The behavioral and physiological effects of high‐fat diet and alcohol consumption: Sex differences in C57BL6/J mice
por: Gelineau, Rachel R., et al.
Publicado: (2017)